Published Paper Details:

Convalescent plasma therapy is a medical technique that harnesses antibodies from recovered individuals to treat infectious diseases. The therapy's historical evolution, mechanisms, and application in various diseases, including COVID-19, cancer, and more, are extensively explored in this review. While convalescent plasma therapy shows promise in enhancing immune responses and combating pathogens, it also presents challenges such as adverse reactions, timing of administration, and limitations in neutralizing antibodies. The review discusses the positive and negative aspects of plasma therapy, shedding light on its clinical efficiency, mortality reduction, and potential complications. Furthermore, it outlines future prospects, including the need for overcoming challenges, development of alternative passive immunization strategies, and the potential for monoclonal antibodies as therapeutic options. The market overview highlights the escalating growth of the Plasma Therapy Market, driven by rising chronic diseases, increased awareness, and advancements in treatment techniques. Recent developments, case studies, and the emergence of innovative companies further contribute to the understanding of convalescent plasma therapy's evolving landscape.